Dr. Shahidi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
618 5th Street
Marysville, CA 95901Phone+1 530-749-4400Fax+1 218-333-5285
Education & Training
- Rush University Medical CenterFellowship, Hematology and Medical Oncology, 1995 - 1998
- Henry Ford Health/Henry Ford HospitalResidency, Internal Medicine, 1992 - 1995
- Hacettepe University FOMClass of 1989
Certifications & Licensure
- CA State Medical License 2008 - 2026
- MN State Medical License 2024 - 2025
- NV State Medical License 2020 - 2021
- ND State Medical License 2002 - 2017
- IL State Medical License 1995 - 1999
- MI State Medical License 1994 - 1998
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Publications & Presentations
PubMed
- 5 citationsBilateral Germ Cell Tumors and Androgen Insensitivity SyndromeHomayoon Shahidi, Mark Robia
Journal of Clinical Oncology. 2007-10-10 - 94 citationsResults of a Phase I trial of concurrent chemotherapy and escalating doses of radiation for unresectable non-small-cell lung cancer.Steven E. Schild, William L. McGinnis, David L. Graham, Shauna Hillman, Tom R. Fitch
International Journal of Radiation Oncology, Biology, Physics. 2005-10-01 - 2 citationsEffectiveness of interferon-alfa and mid-cycle chemotherapy added to an anthracycline-based regimen in the treatment of aggressive non-Hodgkin's lymphoma.Sari H. Enschede, Homayoun Shahidi, Parameswaran Venugopal, Mary Beth Riley, Raywin Huang
Leukemia & Lymphoma. 2001-01-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: